Sonnet BioTherapeutics
SONN
NASDAQ
IPO2020
about SONN
Sonnet BioTherapeutics is a biopharmaceutical company focused on developing innovative oncology treatments, including antibody-drug conjugates and mRNA-based cancer immunotherapies designed to target specific cancers with precision.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $4.15 | $6.65 | $3.97 | $40.28M | 7.62M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.89 | n/a | n/a | 0% | 0% | 0% |